热门资讯> 正文
Surmodics与Premier达成血栓切除产品协议
2024-06-10 20:08
- Surmodics (NASDAQ:SRDX) awarded a group purchasing agreement for thrombectomy products with Premier, effective June 1, 2024.
- The new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Surmodics Pounce and Pounce Venous Thrombectomy Systems.
- Premier is a healthcare improvement company, uniting an alliance of more than 4,350 U.S. hospitals.
More on Surmodics
- Surmodics jumps 18% on acquisition by GTCR
- Surmodics beats top-line and bottom-line estimates; updates FY24 outlook
- Seeking Alpha’s Quant Rating on Surmodics
- Historical earnings data for Surmodics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
